NotesPolymyxin B and colistimethate (cas 12705-41-8) are comparable as to efficacy and renal toxicity
-
Add time:08/28/2019 Source:sciencedirect.com
We compared 41 patients who received colistimethate (cas 12705-41-8) with 41 who received polymyxin B for the treatment of serious infections caused by carbapenem-resistant Acinetobacter spp. and found both polymyxins have similar efficacy and toxicity.
We also recommend Trading Suppliers and Manufacturers of colistimethate (cas 12705-41-8). Pls Click Website Link as below: cas 12705-41-8 suppliers
Prev:Sodium colistimethate (cas 12705-41-8) loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis
Next:Barley nitrate reductase contains a functional cytochrome b557 (cas 12705-48-5)☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Sodium colistimethate (cas 12705-41-8) loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis08/27/2019
- Rapid communicationStability of colistimethate (cas 12705-41-8) sodium in a disposable elastomeric infusion device08/26/2019
- Short communicationA simple method for assaying colistimethate (cas 12705-41-8) sodium in pharmaceutical aerosol samples using high performance liquid chromatography08/25/2019
- Original ArticleSafety and effectiveness of sodium colistimethate (cas 12705-41-8)-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration08/24/2019
- Short communicationPotential pitfalls in LC-MS/MS quantification of colistin for therapeutic drug monitoring of patients treated with colistimethate (cas 12705-41-8)08/23/2019
